advanced search

Welcome: Guest

log in

Pharma Company Profiles - Takeda Pharmaceutical Co.

Publication Date October 2008
Publisher Synergyst
Product Type Report
Pages 40
ISBN Number not applicable
Product Code SYG03223
Price

£275.00
approximately: $402 | €301

PDFBuy Now
PRINT £480 ($701 | €526)Buy Now
CD-ROM £480 ($701 | €526)Buy Now
Order above formats by FAXOrder by FAX

Summary

The success of pharmaceutical companies has always been driven by the successful launches of blockbusters. Now the environment confronting the industry is getting increasingly challenging, as competition, regulatory measures, patent expiry, and healthcare cost-containment measures all are constraining revenue and profit growth. Big Pharma players are redefining the threshold of innovation. In this context, pharmaceutical companies will have to move towards a 'new way of doing business in order to create value for all stakeholders. Those that will be good at anticipating changes and creating new business models will be the real winners.

Synergysts Pharma Company Profiles, extensively analyses the Big Pharma companies and the markets in which they operate. Report covers a detailed analysis of the company focusing on the business segments in which it operates and an analysis of its R&D initiatives and various products it has developed and is developing. Further, the report provides a comprehensive analysis of companys financials, its top competitors and the strategies it is implementing to improve its market position. Report also presents analyst views and earning estimates for the company.

Note: This report may take up to 2-3 working days to get updated and delivered.

Content

  • I. Industry Overview
    • A. Industry Definition And Sic Codes
    • B. Industry Overview And Current Status
    • C. Industry Forecast
  • II. Business Description
    • A. Company Overview
    • B. Detailed Operations
    • C. Geographical Coverage
    • D. Key Products/ Therapeutic Areas
    • E. Key Executives
  • III. Financials
    • A. Annual Financials
    • B. Quarterly Financials
    • C. Stock Performance (If Listed)
    • D. Key Ratios
  • IV. Strategic Analysis
    • A. Business Strategies
    • B. Alliances/ Partnerships
    • C. Mergers/ Acquisitions/ Sell-Offs
    • D. R&D Activities
  • V. Market Competition
    • A. Brief Profiles Of Top 3 Competitors
    • B. Strategies Of Competitors
    • C. Comparative Performance Analysis
  • VI. Forecast
    • A. Earning Estimates
    • B. Future Strategies
  • VII. Appendix
    • A. Recent News
    • B. Income Statement Of Companies Discussed